Novo Nordisk shares rise, Silk Road Medical stock slumps and other movers

Novo Nordisk
NVO,
+1.03%
shares jumped 3% as the Danish drugmaker said it ended a trial early due to efficacy of its diabetes drug Ozempic against kidney disease.

Stock decliners:

Shares of Silk Road Medical Inc.
SILK,
-0.71%
dropped 39% after the medical device company’s forecast fell short of Wall Street estimates, and announced its CEO was retiring.

Shares in Fresenius Medical Care
FMS,
+0.92%
dropped 19% and DaVita
DVA,
+3.14%
stock fell 18% on concerns over future dialysis sales in the wake of the Novo Nordisk trial.

Read the full article here